Epidemiological analysis reveals declining global rheumatic heart disease burden across worldwide populations, highlighting persistent health disparities in impoverished regions.
We estimated the global disease prevalence of and mortality due to rheumatic heart disease over a 25-year period. The health-related burden of rheumatic heart disease has declined worldwide, but high rates of disease persist in some of the poorest regions in the world. (Funded by the Bill and Melinda Gates Foundation and the Medtronic Foundation.).
No takes yet. Share an insight, caveat, or question.
Watkins et al. (2017) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: